P&G/Cygnus
This article was originally published in The Tan Sheet
Executive Summary
Announce agreement under which P&G will have exclusive worldwide marketing rights to "at least two" smoking cessation products currently being developed by Cygnus. The deal does not apply to the Nicotrol nicotine patch, which is being marketed in the U.S. and Canada by McNeil Consumer under a recent pact with Cygnus' licensee Kabi Pharmacia ("The Tan Sheet" Jan. 24, p. 13). Cygnus and P&G have a pre-existing agreement to market an OTC using a nontransdermal Cygnus delivery system